Loading...
Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of µ-Opioid Receptor Agonists but Not Prolonged Precipitated Withdrawal in Rats
A novel µ-opioid receptor antagonist, methocinnamox (MCAM), attenuates some abuse-related and toxic effects of opioids. This study further characterized the pharmacology of MCAM in separate groups of rats using procedures to examine antinociception, gastrointestinal motility, and withdrawal in morph...
Na minha lista:
| Udgivet i: | J Pharmacol Exp Ther |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The American Society for Pharmacology and Experimental Therapeutics
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863459/ https://ncbi.nlm.nih.gov/pubmed/31439807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.119.260331 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|